FilingReader Intelligence
Granules India Q1 revenue rises 3% to Rs12.1bn
August 19, 2025 at 06:49 AM UTC•By FilingReader AI
Granules India reported Q1 FY26 revenue of Rs12.1bn, up 3% year-on-year, including Rs291m from Senn Chemicals acquisition. Gross margin improved to 64.9% but EBITDA fell to Rs2.47bn due to increased professional expenses for US FDA observation remediation.
The company expects to return to growth by Q4 FY26, with its new Genome Valley facility fully operational by Q1 FY27.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:GRANULES•Bombay Stock Exchange
News Alerts
Get instant email alerts when Granules India publishes news
Free account required • Unsubscribe anytime